(MedPage Today) — The content, formatting, and word count of leaflets pharmacies hand out with medicines are inconsistent and should be subject to FDA guidance, researchers say.
No Comments »
Filed under: General Health News
(MedPage Today) — NEW BRUNSWICK, N.J. — About 50 physicians and their families gathered at Buccleuch Park here on Saturday for a physicians’ “tea party” to air their frustrations with the new healthcare law.
No Comments »
Filed under: General Health News
(MedPage Today) — The FDA announced the recall of three products marketed as dietary supplements but which the agency found to contain undeclared drug ingredients.
No Comments »
Filed under: General Health News
(MedPage Today) — The FDA is seeking to stop a Colorado company from offering an autologous stem cell therapy for arthritic knees and other orthopedic problems, which the agency says is unapproved, misbranded, and adulterated.
No Comments »
Filed under: General Health News
(MedPage Today) — The first documented outbreak of human salmonellosis traced to dry pet food may have been largely transmitted by cross-contamination after feeding a pet in the kitchen, according to CDC investigators.
No Comments »
Filed under: General Health News
(MedPage Today) — Certain types of filters inserted into the inferior vena cava to prevent pulmonary emboli appear to have a high risk of fracture and other adverse events — leading to life-threatening complications in some cases, according to a warning from the FDA and a new study.
No Comments »
Filed under: Pharmacy News
(MedPage Today) — The FDA announced the recall of three products marketed as dietary supplements but which the agency found to contain undeclared drug ingredients.
No Comments »
Filed under: Pharmacy News
(MedPage Today) — The FDA is seeking to stop a Colorado company from offering an autologous stem cell therapy for arthritic knees and other orthopedic problems, which the agency says is unapproved, misbranded, and adulterated.
No Comments »
Filed under: Pharmacy News
Curis, Inc., a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, today announced that it has received preliminary results from a Phase II clinical trial of GDC-0449 from Roche and Genentech, Curis’ collaborator and a member of the Roche Group.
No Comments »
Filed under: Pharmacy News
BELLUS Health Inc. reported today its financial results for the second quarter ended June 30, 2010. The Company also announced new initiatives to reduce its annual expenditures (”burn rate”) by focusing its efforts on existing products and on supporting current and future strategic partnerships. All currency figures reported in this press release, including comparative figures, [...]
No Comments »
Filed under: Pharmacy News
